Pharmaceutical companies accused of breaking competition law
The Competition and Markets Authority has provisionally found that four pharmaceutical companies broke the law by agreeing not to compete in the supply of an anti-nausea drug in the UK. It alleges that, between 2013 and 2018, Alliance, Focus, Lexon and Medreich agreed not to compete for the supply of Prochlorperazine tablets to the NHS.